Sensus Healthcare, Inc. (NASDAQ:SRTS)

Sunday, December 8, 2024 | Web News
Sensus Healthcare, Inc. (NASDAQ:SRTS) partners with Pompano Veterinary Oncology to pioneer the use of SRT to treat companion animals across South Florida via the use...
See All Research...
Sunday, December 8, 2024, 5:26 PM
Important GeoInvesting Portfolio Moves Support Shifting Microcap Investor Focus [GeoWire Weekly No. 165]
Sunday, November 24, 2024, 4:30 PM
Contributor Thomas Birnie Case Study Points To Clues For Another Brewing Multibagger Plus Our Final Thoughts on TSSI Q3 [GeoWire Weekly No. 163]
Sunday, August 11, 2024, 11:21 AM
Meet Sam McColgan, A New Full-Time Microcap Investor We’re Predicting Great Things From [GeoWire Weekly No. 148]
See All GeoWire Weekly...

Sensus Healthcare, Inc. manufactures and markets superficial radiation therapy devices to healthcare providers worldwide. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides Sentinel service program, which offers its customers protection for their SRT-100 and SRT-100 Vision systems. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons, eye shields, and disposable applicator tips, which are used to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was founded in 2010 and is headquartered in Boca Raton, Florida.

Last updated September 20, 2018


Market Data powered by QuoteMedia. Terms of Use